Ainul Basirah Ibramsah Aliff Irwan Cheong Wan Norliza Wan Muda Mohtar Ibrahim
10.22336/rjo.2022.7
Rom J Ophthalmol
2022 Jan-Mar;66(1):27-31.
fibrin fibrinolysis phacoemulsification
CC BY
https://pubmed.ncbi.nlm.nih.gov/35531461/
Cataract / complications Eye Diseases / etiology Phacoemulsification / adverse effects Tissue Plasminogen Activator / therapeutic use
Cataract / complications Eye Diseases / etiology Phacoemulsification / adverse effects Tissue Plasminogen Activator / therapeutic use Case Reports Review Female Fibrin Fibrinolytic Agents / therapeutic use Humans Middle Aged Recombinant Proteins / therapeutic use Fibrinolytic Agents Recombinant Proteins Fibrin Tissue Plasminogen Activator
PMC9022144
35531461
The efficacy of recombinant tissue plasminogen activator in severe post-operative fibrinous reaction after uneventful phacoemulsification - a case series and review
2022